In our February issue of Pharmaceutical Executive FEATURES
Cover Story Dr. Xiaobin Wu: A Leading Man's Next Act Lisa Henderson
A profile of Dr. Xiaobin Wu, an accomplished leader in helming China operations at big pharmas such as Pfizer and Bayer, who believes his recent jump to biotech as GM of China and president of BeiGene will deliver his most lasting legacy.
China Focus A Change in Attitude Lisa Henderson
How innovation growth has upped the pressure on China to compete globally, forcing upgrades in regulatory, quality, and standards.
China Focus New Roads to China Julian Upton
How the nation's rapidly changing regulatory climate is creating a new landscape for pharmaceutical service providers.
ALSO IN THIS ISSUE Two Steps Forward Lisa Henderson
Green-lighting China as our coverage focus in the February issue wasn't without conflict or hesitation, but as our reporting of the nation's biopharma landscape shows, perseverance and growth many times go hand-in-hand …Read more